Inflecting Value in Early Stage Biotech: Linking Proof of Relevance to Pricing & Reimbursement

Tuesday, May 5, 2020 | 3:30 – 4:45 pm


  • Ed Saltzman, Executive Chairman, Cello Heath BioConsulting


  • Robert Glassman, MD, Vice-Chairman, Global Health Care Investment Banking, Credit Suisse;
    Clinical Assistant Professor, Division of Hematology-Oncology, Weill-Cornell Medical College
  • Anna Kaltenboeck, Senior Health Economist & Program Director for the Center for Health Policy and Outcomes,and the Drug Pricing Lab at Memorial Sloan Kettering Cancer Center
  • Michael Kolodziej, Vice President and Chief Innovation Officer, ADVI
  • David Weinstein, MSc, Senior Director, Celgene